Also trades as: 1873.HK (HKSE) · $vol 1M
VBIZF OTC
Viva Biotech Holdings
1W: +0.0%
1M: +0.0%
3M: +42.1%
YTD: -1.1%
1Y: -31.6%
3Y: -4.4%
5Y: -83.2%
$0.19
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$7.1B
-5.4% ▼
5Y CAGR: +30.0%
Total Liabilities
$3.2B
-14.0% ▼
5Y CAGR: +92.8%
Shareholders Equity
$3.8B
+3.1% ▲
5Y CAGR: +16.4%
Cash & Investments
$942M
-9.1% ▼
5Y CAGR: +0.2%
Total Debt
$1.3B
-32.5% ▼
5Y CAGR: +91.8%
Net Debt
$342M
-60.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2.3B | $801M | $679M | $1.0B | $942M |
| Short-Term Investments | $50M | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $2.4B | $801M | $679M | $1.0B | $942M |
| Net Receivables | $321M | $430M | $446M | $407M | $437M |
| Inventory | $165M | $232M | $326M | $260M | $273M |
| Other Current Assets | $502M | $514M | $480M | $322M | $207M |
| Total Current Assets | $3.4B | $2.0B | $1.9B | $2.0B | $1.9B |
| Property, Plant & Equip. | $737M | $1.7B | $1.9B | $1.7B | $1.6B |
| Goodwill & Intangibles | $2.3B | $2.7B | $2.6B | $2.6B | $2.5B |
| Long-Term Investments | $925M | $1.2B | $1.0B | $1.0B | $989M |
| Other Non-Current Assets | -$10M | -$8M | -$18M | $149M | $35M |
| Total Non-Current Assets | $4.0B | $5.7B | $5.6B | $5.4B | $5.2B |
| Total Assets | $8.2B | $8.0B | $7.9B | $7.4B | $7.1B |
| — Liabilities — | |||||
| Accounts Payable | $296M | $281M | $326M | $246M | $309M |
| Short-Term Debt | $156M | $233M | $1.9B | $950M | $549M |
| Deferred Revenue | $0 | -$239M | -$1.9B | $0 | $0 |
| Other Current Liabilities | $273M | $540M | $2.2B | $203M | $51M |
| Total Current Liabilities | $736M | $927M | $2.7B | $1.5B | $1.1B |
| Long-Term Debt | $2.8B | $2.4B | $881M | $922M | $706M |
| Other Non-Current Liab. | $717M | $596M | $572M | $1.2B | $1.3B |
| Total Non-Current Liabilities | $3.7B | $3.2B | $1.6B | $2.2B | $2.1B |
| Total Liabilities | $4.4B | $4.1B | $4.3B | $3.8B | $3.2B |
| — Equity — | |||||
| Common Stock | $323K | $326K | $326K | $367K | $367K |
| Retained Earnings | $63M | $350M | -$178M | -$295M | -$127M |
| Accumulated OCI | $96M | $61M | $280M | $243M | $213M |
| Total Stockholders Equity | $3.8B | $3.9B | $3.6B | $3.7B | $3.8B |
| Total Liabilities & Equity | $8.2B | $8.0B | $7.9B | $7.4B | $7.1B |
| — Key Metrics — | |||||
| Total Debt | $3.0B | $2.7B | $2.8B | $1.9B | $1.3B |
| Net Debt | $661M | $1.9B | $2.1B | $867M | $342M |
| Total Investments | $974M | $1.2B | $1.0B | $1.0B | $989M |